Monday, 18 June 2018 - 4:27
  • it
  • de
  • en
  • fr

Top stories

News of the week

NASH sector heats up

Bloomberg yesterday reported that biotech Madrigal Pharmaceuticals  is weighing a sale after some early talks with large pharmaceutical groups. The news has made Madrigal’s shares jump by over 150% in the last month. Madrigal is a biotech based in Pennsylvania,…

Here is the salary of pharma CEOs

Approvals

Procedures / New drug and device authorizations / Recommendations

Good news from Pfizer: talazoparib obtains accelerated assessment procedure for breast cancer

Good news for US-based Pfizer: the FDA yesterday granted the Priority Review designation to cancer therapy talazoparib. Talazoparib is a PARP (Poly ADP ribose polymerase) inhibitor, which  induces tumor cell death by blocking PARP enzyme activity. Talazoparib has been tested with…

Companies

Healthcare market news

NASH sector heats up

Bloomberg yesterday reported that biotech Madrigal Pharmaceuticals  is weighing a sale after some early talks with large pharmaceutical groups. The news has made Madrigal’s shares jump by over 150% in the last month. Madrigal is a biotech based in Pennsylvania,…

Chemistry

Market and Technology

Saint Gobain renounces to acquire Sika but buys 10% stake

Saint-Gobain and Sika have announced today a complex agreement through which Saint Gobain has renounced to acquire the Switzerland-based competitor. As part of the agreement, Saint Gobain will purchase €3.22bn in shares currently owned by the Burkhard family and will…

M&A

Mergers & Acquisitions

NASH sector heats up

Bloomberg yesterday reported that biotech Madrigal Pharmaceuticals  is weighing a sale after some early talks with large pharmaceutical groups. The news has made Madrigal’s shares jump by over 150% in the last month. Madrigal is a biotech based in Pennsylvania,…

Nutraceuticals

Food supplements

Mybiotics licenses to Ferring technology using bacterial flora to treat female diseases

Israel-based Mybiotics Pharma has signed an agreement with Ferring Holding to license the use of its MyCrobe technology, aimed at developing bacteria that benefit women’s health. MyCrobe has developed bacterial fermentation techniques based on the study of interactions between intestinal…

Pathology

Latest developments

NASH sector heats up

Bloomberg yesterday reported that biotech Madrigal Pharmaceuticals  is weighing a sale after some early talks with large pharmaceutical groups. The news has made Madrigal’s shares jump by over 150% in the last month. Madrigal is a biotech based in Pennsylvania,…

Safety

News on Product Safety

FDA issues warning about Intercept’s Ocaliva after 19 patients died

The FDA has officially warned doctors about the risks from Intercept Pharmaceuticals’ Ocaliva (obeticholic acid), after 19 patients on Intercept’s drug, developed to treat PBC (Primary Biliary Cholangitis) had died. The FDA, anyway, has specified that the deaths have occurred…

Trials

Preclinical Trials / Clinical Trials / Epidemiology

Good news from Pfizer: talazoparib obtains accelerated assessment procedure for breast cancer

Good news for US-based Pfizer: the FDA yesterday granted the Priority Review designation to cancer therapy talazoparib. Talazoparib is a PARP (Poly ADP ribose polymerase) inhibitor, which  induces tumor cell death by blocking PARP enzyme activity. Talazoparib has been tested with…